Real-world treatment sequencing and survival in previously treated advanced renal cell carcinoma patients receiving nivolumab monotherapy: a UK retrospective cohort study

BACKGROUND: The CheckMate 025 trial established nivolumab monotherapy as one of the standards of care in previously treated advanced or metastatic renal cell carcinoma (aRCC). However, supporting real-world data is lacking. This study investigated characteristics, treatment sequences and clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Waddell, T., Fife, K., Griffiths, R., Sharma, A., Dhokia, P., Groves, L., Hurst, M., Tsang, C., Sugrue, D., McKenna, S., Houghton, J., Carroll, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169585/
https://www.ncbi.nlm.nih.gov/pubmed/35668384
http://dx.doi.org/10.1186/s12885-022-09694-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169585/
https://www.ncbi.nlm.nih.gov/pubmed/35668384
http://dx.doi.org/10.1186/s12885-022-09694-y

Ejemplares similares